English

Alterola Biotech Inc.

EDGAR

Quarterly report (10-Q) · filed 2024-11-29

68 filing records in this dataset, filed from 2009-02-17 to 2024-11-29. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2025 Q2 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-861 thousand USD

2025 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -1067729 USD Source
Operating Cash Flow: -207163 USD Source

Cash and cash equivalents: 82.7 thousand USD 2024-09-30 Source
Exact value

82720 USD
Long-term debt including current maturities: 20 thousand USD 2023-09-30 Source
Exact value

19950 USD
Shares outstanding: 1.47 billion shares 2024-09-30 Source
Exact value

1467475449 shares

Reported share-count change

88.61% · 689 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

778031952 shares · 2023-09-30· Source
1467475449 shares · 2024-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-2.97 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Net income: -2010322 USD · 2023-10-01 – 2023-12-31 Source
Net income: -2374379 USD · 2023-04-01 – 2024-03-31 Source
Net income: -2865209 USD · 2023-04-01 – 2023-12-31 Source
Net income: -654747 USD · 2024-04-01 – 2024-06-30 Source
Net income: -799193 USD · 2024-07-01 – 2024-09-30 Source

Operating cash flow

-2.32 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Operating cash flow: -1373496 USD · 2023-04-01 – 2023-12-31 Source
Operating cash flow: -197625 USD · 2023-04-01 – 2023-09-30 Source
Operating cash flow: -1447088 USD · 2023-04-01 – 2024-03-31 Source
Operating cash flow: -1373496 USD · 2023-04-01 – 2023-12-31 Source
Operating cash flow: -207163 USD · 2024-04-01 – 2024-06-30 Source
Operating cash flow: -1067729 USD · 2024-04-01 – 2024-09-30 Source
Operating cash flow: -207163 USD · 2024-04-01 – 2024-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-11-29.

Financial data available through: 2024-03-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2019-09-30
Operating income: 11 of 11 periods available· newest 2024-03-31
Net income: 11 of 11 periods available· newest 2024-03-31
Operating cash flow: 11 of 11 periods available· newest 2024-03-31
capital expenditure: No compatible figures in this window
Total assets: 10 of 11 periods available· newest 2024-03-31
Total liabilities: 9 of 11 periods available· newest 2024-03-31
Current assets: 9 of 11 periods available· newest 2024-03-31
Current liabilities: 11 of 11 periods available· newest 2024-03-31
Cash and cash equivalents: 9 of 11 periods available· newest 2024-03-31
Long-term debt including current maturities: 5 of 11 periods available· newest 2019-09-30
Shares outstanding: 5 of 11 periods available· newest 2024-03-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 303,193

Prior period

−USD 2.07 million

2022-04-01 – 2023-03-31
Current period

−USD 2.37 million

2023-04-01 – 2024-03-31

Exact inputs and evidence

-2374379 − -2071186 = -303193 USD

-2071186 USD · 2022-04-01 – 2023-03-31
Inspect prior input Prior source
-2374379 USD · 2023-04-01 – 2024-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Alterola Biotech Inc. · 2024-03-31 Alterola Biotech Inc. (edgar:1442999) Year-over-year change in Net income: -303193 USD Concept: fundies:NetIncome Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2374379 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357724000211/abti10k_033124.htm#624861 Filing: 000166357724000211 Input fundies:NetIncome: -2071186 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357724000211/abti10k_033124.htm#713755 Filing: 000166357724000211
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 139,824

Prior period

−USD 1.31 million

2022-04-01 – 2023-03-31
Current period

−USD 1.45 million

2023-04-01 – 2024-03-31

Exact inputs and evidence

-1447088 − -1307264 = -139824 USD

-1307264 USD · 2022-04-01 – 2023-03-31
Inspect prior input Prior source
-1447088 USD · 2023-04-01 – 2024-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Alterola Biotech Inc. · 2024-03-31 Alterola Biotech Inc. (edgar:1442999) Year-over-year change in Operating cash flow: -139824 USD Concept: fundies:OperatingCashFlow Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1447088 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357724000211/abti10k_033124.htm#643183 Filing: 000166357724000211 Input fundies:OperatingCashFlow: -1307264 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357724000211/abti10k_033124.htm#716772 Filing: 000166357724000211
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2020 2018-10-01 – 2019-09-30

Revenue USD 0
Operating costs Derived USD 258,453
Operating income −USD 258,453
Tax, interest and other Derived USD 249
Net income −USD 258,702

Cash

Operating cash flow USD 0
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.
2020 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2015-10-01 – 2016-09-30	14731 Derived	-14731	7846 Derived	-22577	Unavailable	Source 2015-10-01 – 2016-09-30: 0 USD Inspect Revenue Open source 2015-10-01 – 2016-09-30: -14731 USD Inspect Operating Income Open source 2015-10-01 – 2016-09-30: -22577 USD Inspect Net Income Open source 2015-10-01 – 2016-09-30: -27631 USD Inspect Operating Cash Flow Open source
2018 2016-10-01 – 2017-09-30	49132 Derived	-49132	18500 Derived	-67632	Unavailable	Source 2016-10-01 – 2017-09-30: 0 USD Inspect Revenue Open source 2016-10-01 – 2017-09-30: -49132 USD Inspect Operating Income Open source 2016-10-01 – 2017-09-30: -67632 USD Inspect Net Income Open source 2016-10-01 – 2017-09-30: 0 USD Inspect Operating Cash Flow Open source
2019 2017-10-01 – 2018-09-30	122557 Derived	-122557	-9490 Derived	-113067	Unavailable	Source 2017-10-01 – 2018-09-30: 0 USD Inspect Revenue Open source 2017-10-01 – 2018-09-30: -122557 USD Inspect Operating Income Open source 2017-10-01 – 2018-09-30: -113067 USD Inspect Net Income Open source 2017-10-01 – 2018-09-30: -19950 USD Inspect Operating Cash Flow Open source
2020 2018-10-01 – 2019-09-30	258453 Derived	-258453	249 Derived	-258702	Unavailable	Source 2018-10-01 – 2019-09-30: 0 USD Inspect Revenue Open source 2018-10-01 – 2019-09-30: -258453 USD Inspect Operating Income Open source 2018-10-01 – 2019-09-30: -258702 USD Inspect Net Income Open source 2018-10-01 – 2019-09-30: 0 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2020

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
20162015-09-30	Revenue	Revenue: 0 Open source
20172016-09-30	Revenue	Revenue: 0 Open source
20182017-09-30	Revenue	Revenue: 0 Open source
20192018-09-30	Revenue	Revenue: 0 Open source
20202019-09-30	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162015-09-30	Year over year	No prior comparable period	Revenue: 0 Open source
20172016-09-30	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20182017-09-30	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20192018-09-30	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20202019-09-30	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162015-09-30	Operating margin	Not reported	Operating Income: -20402 Open source Revenue: 0 Open source
20172016-09-30	Operating margin	Not reported	Operating Income: -14731 Open source Revenue: 0 Open source
20182017-09-30	Operating margin	Not reported	Operating Income: -49132 Open source Revenue: 0 Open source
20192018-09-30	Operating margin	Not reported	Operating Income: -122557 Open source Revenue: 0 Open source
20202019-09-30	Operating margin	Not reported	Operating Income: -258453 Open source Revenue: 0 Open source
20162015-09-30	Net margin	Not reported	Net Income: -36127 Open source Revenue: 0 Open source
20172016-09-30	Net margin	Not reported	Net Income: -22577 Open source Revenue: 0 Open source
20182017-09-30	Net margin	Not reported	Net Income: -67632 Open source Revenue: 0 Open source
20192018-09-30	Net margin	Not reported	Net Income: -113067 Open source Revenue: 0 Open source
20202019-09-30	Net margin	Not reported	Net Income: -258702 Open source Revenue: 0 Open source
20162015-09-30	Free cash flow margin	Not reported	Revenue: 0 Open source
20172016-09-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -27631 Open source
20182017-09-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 0 Open source
20192018-09-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -19950 Open source
20202019-09-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 0 2020

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162015-09-30	Operating cash flow	Not reported	No source recorded
20172016-09-30	Operating cash flow	-27631	Operating Cash Flow: -27631 Open source
20182017-09-30	Operating cash flow	0	Operating Cash Flow: 0 Open source
20192018-09-30	Operating cash flow	-19950	Operating Cash Flow: -19950 Open source
20202019-09-30	Operating cash flow	0	Operating Cash Flow: 0 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162015-09-30	Free cash flow	Unavailable	No source recorded
20172016-09-30	Free cash flow	Unavailable	Operating Cash Flow: -27631 Open source
20182017-09-30	Free cash flow	Unavailable	Operating Cash Flow: 0 Open source
20192018-09-30	Free cash flow	Unavailable	Operating Cash Flow: -19950 Open source
20202019-09-30	Free cash flow	Unavailable	Operating Cash Flow: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

1,475.1% 2020

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-09-30	Liabilities / assets	Not reported	Total Assets: 8314 Open source
2016-09-30	Liabilities / assets	Not reported	Total Assets: 2583 Open source
20182017-09-30	Liabilities / assets	Not reported	Total Liabilities: 294678 Open source
20192018-09-30	Liabilities / assets	209.5%	Total Liabilities: 106309 Open source Total Assets: 50742 Open source
20202019-09-30	Liabilities / assets	1,475.1%	Total Liabilities: 217452 Open source Total Assets: 14742 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.07× 2020

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162015-09-30	Current assets / current liabilities	0.01×	Current Assets: 2631 Open source Current Liabilities: 249783 Open source
2016-09-30	Current assets / current liabilities	Not reported	Current Liabilities: 266629 Open source
2017-09-30	Current assets / current liabilities	Not reported	Current Liabilities: 294678 Open source
20192018-09-30	Current assets / current liabilities	0.59×	Current Assets: 50742 Open source Current Liabilities: 86359 Open source
20202019-09-30	Current assets / current liabilities	0.07×	Current Assets: 14742 Open source Current Liabilities: 217452 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2015-10-01 – 2016-09-30	−USD 22,577 Exact value Exact value: -22577 USD 2015-10-01 – 2016-09-30: -22577 USD Inspect Net Income Open source Share or cite Citation for Net Income · Alterola Biotech Inc. · 2016-09-30 Alterola Biotech Inc. (edgar:1442999) Net Income: -22577 USD Concept: fundies:NetIncome Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3ANetIncome&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:NetIncome: -22577 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357720000514/abti-20181231.xml#48775 Filing: 000166357720000514 The citation records this snapshot. The page link may show a newer release later.	−USD 27,631 Exact value Exact value: -27631 USD 2015-10-01 – 2016-09-30: -27631 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Alterola Biotech Inc. · 2016-09-30 Alterola Biotech Inc. (edgar:1442999) Operating Cash Flow: -27631 USD Concept: fundies:OperatingCashFlow Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3AOperatingCashFlow&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27631 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357718000560/alta-20170930.xml#88948 Filing: 000166357718000560 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2016-10-01 – 2017-09-30	−USD 67,632 Exact value Exact value: -67632 USD 2016-10-01 – 2017-09-30: -67632 USD Inspect Net Income Open source Share or cite Citation for Net Income · Alterola Biotech Inc. · 2017-09-30 Alterola Biotech Inc. (edgar:1442999) Net Income: -67632 USD Concept: fundies:NetIncome Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3ANetIncome&period=2017-09-30&surface=latest&period_type=duration&start=2016-10-01&unit=USD&dimensions= Input fundies:NetIncome: -67632 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357720000514/abti-20181231.xml#48900 Filing: 000166357720000514 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2016-10-01 – 2017-09-30: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Alterola Biotech Inc. · 2017-09-30 Alterola Biotech Inc. (edgar:1442999) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3AOperatingCashFlow&period=2017-09-30&surface=latest&period_type=duration&start=2016-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357720000468/abti-20180930.xml#84130 Filing: 000166357720000468 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2017-10-01 – 2018-09-30	−USD 113,067 Exact value Exact value: -113067 USD 2017-10-01 – 2018-09-30: -113067 USD Inspect Net Income Open source Share or cite Citation for Net Income · Alterola Biotech Inc. · 2018-09-30 Alterola Biotech Inc. (edgar:1442999) Net Income: -113067 USD Concept: fundies:NetIncome Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3ANetIncome&period=2018-09-30&surface=latest&period_type=duration&start=2017-10-01&unit=USD&dimensions= Input fundies:NetIncome: -113067 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357721000147/abti-20190930.xml#171721 Filing: 000166357721000147 The citation records this snapshot. The page link may show a newer release later.	−USD 19,950 Exact value Exact value: -19950 USD 2017-10-01 – 2018-09-30: -19950 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Alterola Biotech Inc. · 2018-09-30 Alterola Biotech Inc. (edgar:1442999) Operating Cash Flow: -19950 USD Concept: fundies:OperatingCashFlow Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3AOperatingCashFlow&period=2018-09-30&surface=latest&period_type=duration&start=2017-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19950 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357721000147/abti-20190930.xml#56278 Filing: 000166357721000147 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2018-10-01 – 2019-09-30	−USD 258,702 Exact value Exact value: -258702 USD 2018-10-01 – 2019-09-30: -258702 USD Inspect Net Income Open source Share or cite Citation for Net Income · Alterola Biotech Inc. · 2019-09-30 Alterola Biotech Inc. (edgar:1442999) Net Income: -258702 USD Concept: fundies:NetIncome Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3ANetIncome&period=2019-09-30&surface=latest&period_type=duration&start=2018-10-01&unit=USD&dimensions= Input fundies:NetIncome: -258702 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357721000273/abti-20201231.xml#46102 Filing: 000166357721000273 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2018-10-01 – 2019-09-30: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Alterola Biotech Inc. · 2019-09-30 Alterola Biotech Inc. (edgar:1442999) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3AOperatingCashFlow&period=2019-09-30&surface=latest&period_type=duration&start=2018-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357721000259/abti-20200930.xml#32282 Filing: 000166357721000259 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2019-10-01 – 2020-09-30	−USD 250,511 Exact value Exact value: -250511 USD 2019-10-01 – 2020-09-30: -250511 USD Inspect Net Income Open source Share or cite Citation for Net Income · Alterola Biotech Inc. · 2020-09-30 Alterola Biotech Inc. (edgar:1442999) Net Income: -250511 USD Concept: fundies:NetIncome Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3ANetIncome&period=2020-09-30&surface=latest&period_type=duration&start=2019-10-01&unit=USD&dimensions= Input fundies:NetIncome: -250511 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357721000273/abti-20201231.xml#46228 Filing: 000166357721000273 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2019-10-01 – 2020-09-30: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Alterola Biotech Inc. · 2020-09-30 Alterola Biotech Inc. (edgar:1442999) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3AOperatingCashFlow&period=2020-09-30&surface=latest&period_type=duration&start=2019-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357721000259/abti-20200930.xml#32104 Filing: 000166357721000259 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2020-04-01 – 2021-03-31	−USD 309,500 Exact value Exact value: -309500 USD 2020-04-01 – 2021-03-31: -309500 USD Inspect Net Income Open source Share or cite Citation for Net Income · Alterola Biotech Inc. · 2021-03-31 Alterola Biotech Inc. (edgar:1442999) Net Income: -309500 USD Concept: fundies:NetIncome Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3ANetIncome&period=2021-03-31&surface=latest&period_type=duration&start=2020-04-01&unit=USD&dimensions= Input fundies:NetIncome: -309500 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357722000545/abti10ka.htm#498755 Filing: 000166357722000545 The citation records this snapshot. The page link may show a newer release later.	−USD 50,000 Exact value Exact value: -50000 USD 2020-04-01 – 2021-03-31: -50000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Alterola Biotech Inc. · 2021-03-31 Alterola Biotech Inc. (edgar:1442999) Operating Cash Flow: -50000 USD Concept: fundies:OperatingCashFlow Period: 2020-04-01 to 2021-03-31 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3AOperatingCashFlow&period=2021-03-31&surface=latest&period_type=duration&start=2020-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -50000 USD (2020-04-01 to 2021-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357722000545/abti10ka.htm#506392 Filing: 000166357722000545 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2021-01-19 – 2021-12-31	−USD 343,033 Exact value Exact value: -343033 USD 2021-01-19 – 2021-12-31: -343033 USD Inspect Net Income Open source Share or cite Citation for Net Income · Alterola Biotech Inc. · 2021-12-31 Alterola Biotech Inc. (edgar:1442999) Net Income: -343033 USD Concept: fundies:NetIncome Period: 2021-01-19 to 2021-12-31 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-19&unit=USD&dimensions= Input fundies:NetIncome: -343033 USD (2021-01-19 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357723000080/abti10q.htm#175012 Filing: 000166357723000080 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2022 2021-04-01 – 2022-03-31	−USD 6.47 million Exact value Exact value: -6471134 USD 2021-04-01 – 2022-03-31: -6471134 USD Inspect Net Income Open source Share or cite Citation for Net Income · Alterola Biotech Inc. · 2022-03-31 Alterola Biotech Inc. (edgar:1442999) Net Income: -6471134 USD Concept: fundies:NetIncome Period: 2021-04-01 to 2022-03-31 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3ANetIncome&period=2022-03-31&surface=latest&period_type=duration&start=2021-04-01&unit=USD&dimensions= Input fundies:NetIncome: -6471134 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357723000336/abti10k033123.htm#669024 Filing: 000166357723000336 The citation records this snapshot. The page link may show a newer release later.	USD 44,344 Exact value Exact value: 44344 USD 2021-04-01 – 2022-03-31: 44344 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Alterola Biotech Inc. · 2022-03-31 Alterola Biotech Inc. (edgar:1442999) Operating Cash Flow: 44344 USD Concept: fundies:OperatingCashFlow Period: 2021-04-01 to 2022-03-31 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3AOperatingCashFlow&period=2022-03-31&surface=latest&period_type=duration&start=2021-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 44344 USD (2021-04-01 to 2022-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357723000336/abti10k033123.htm#689859 Filing: 000166357723000336 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2022-04-01 – 2023-03-31	−USD 2.07 million Exact value Exact value: -2071186 USD 2022-04-01 – 2023-03-31: -2071186 USD Inspect Net Income Open source Share or cite Citation for Net Income · Alterola Biotech Inc. · 2023-03-31 Alterola Biotech Inc. (edgar:1442999) Net Income: -2071186 USD Concept: fundies:NetIncome Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3ANetIncome&period=2023-03-31&surface=latest&period_type=duration&start=2022-04-01&unit=USD&dimensions= Input fundies:NetIncome: -2071186 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357724000211/abti10k_033124.htm#713755 Filing: 000166357724000211 The citation records this snapshot. The page link may show a newer release later.	−USD 1.31 million Exact value Exact value: -1307264 USD 2022-04-01 – 2023-03-31: -1307264 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Alterola Biotech Inc. · 2023-03-31 Alterola Biotech Inc. (edgar:1442999) Operating Cash Flow: -1307264 USD Concept: fundies:OperatingCashFlow Period: 2022-04-01 to 2023-03-31 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3AOperatingCashFlow&period=2023-03-31&surface=latest&period_type=duration&start=2022-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1307264 USD (2022-04-01 to 2023-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357724000211/abti10k_033124.htm#716772 Filing: 000166357724000211 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2023-04-01 – 2024-03-31	−USD 2.37 million Exact value Exact value: -2374379 USD 2023-04-01 – 2024-03-31: -2374379 USD Inspect Net Income Open source Share or cite Citation for Net Income · Alterola Biotech Inc. · 2024-03-31 Alterola Biotech Inc. (edgar:1442999) Net Income: -2374379 USD Concept: fundies:NetIncome Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3ANetIncome&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=USD&dimensions= Input fundies:NetIncome: -2374379 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357724000211/abti10k_033124.htm#624861 Filing: 000166357724000211 The citation records this snapshot. The page link may show a newer release later.	−USD 1.45 million Exact value Exact value: -1447088 USD 2023-04-01 – 2024-03-31: -1447088 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Alterola Biotech Inc. · 2024-03-31 Alterola Biotech Inc. (edgar:1442999) Operating Cash Flow: -1447088 USD Concept: fundies:OperatingCashFlow Period: 2023-04-01 to 2024-03-31 Values: Latest reported Published: 2026-11-02T20:07:28Z Snapshot: 71caeac1c049f9cee3a86f26c2d8fef6f4403e730d3f08da136236279368f7f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1442999/explain?concept=fundies%3AOperatingCashFlow&period=2024-03-31&surface=latest&period_type=duration&start=2023-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1447088 USD (2023-04-01 to 2024-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1442999/000166357724000211/abti10k_033124.htm#643183 Filing: 000166357724000211 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

68 filings · 2,175 latest values · 2,175 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001442999, 1442999, edgar:1442999

Also known as ALTEROLA BIOTECH INC., Alterola Biotech, Inc., Alterola Biotech Inc., Alterola Biotech, Inc., JEDEDIAH RESOURCES CORP.

Alterola Biotech Inc.

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2020 2018-10-01 – 2019-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation